At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LNAI Lunai Bioworks
Closed Christmas Day 12-24 13:00:00 EST
0.9860
-0.0062
-0.62%
盘后1.04
+0.0540+5.48%
16:47 EST
High1.05Low0.9700Vol32.46K
Open1.02D1 Closing0.9922Amplitude8.25%
Mkt Cap23.10MTradable Cap14.79MTotal Shares23.43M
T/O32.46KT/O Rate0.22%Tradable Shares15.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Lunai Bioworks Inc - Identifies Three Parkinson's Disease Subtypes
THOMSON REUTERS  ·  12-09
Lunai Bioworks Inc - Identifies Three Parkinson's Disease Subtypes
Lunai Bioworks Inc - Prioritized Drug Targets in $13 Bln Parkinson's Market
THOMSON REUTERS  ·  12-09
Lunai Bioworks Inc - Prioritized Drug Targets in $13 Bln Parkinson's Market
Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritizes Drug Targets
Reuters  ·  12-09
Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritizes Drug Targets
BRIEF-Lunai Bioworks - Enters Sales Agreement With Dawson James Securities - SEC Filing
Reuters  ·  12-03
BRIEF-Lunai Bioworks - Enters Sales Agreement With Dawson James Securities - SEC Filing
Lunai Bioworks Inc - May Offer & Sell Stock up to $11.70 Mln - SEC Filing
THOMSON REUTERS  ·  12-03
Lunai Bioworks Inc - May Offer & Sell Stock up to $11.70 Mln - SEC Filing
Lunai Bioworks Raises $3.1 Million in Private Placement of Shares and Warrants
Reuters  ·  11-26
Lunai Bioworks Raises $3.1 Million in Private Placement of Shares and Warrants
Lunai Bioworks Secures First Licensing LOI for Immune Cell Therapy
Reuters  ·  11-25
Lunai Bioworks Secures First Licensing LOI for Immune Cell Therapy
Lunai Bioworks Secures First Licensing Loi Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models
THOMSON REUTERS  ·  11-25
Lunai Bioworks Secures First Licensing Loi Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models
Lunai Bioworks Achieves Complete Regression of Both Primary and Metastatic Pancreatic Tumors in Preclinical Humanized Models, Marking a Breakthrough in Allogeneic Cancer Immunotherapy
THOMSON REUTERS  ·  11-15
Lunai Bioworks Achieves Complete Regression of Both Primary and Metastatic Pancreatic Tumors in Preclinical Humanized Models, Marking a Breakthrough in Allogeneic Cancer Immunotherapy
Lunai Bioworks Announces Breakthrough Allogeneic Cell Therapy Reversing Pancreatic Tumors in Preclinical Models
Reuters  ·  11-08
Lunai Bioworks Announces Breakthrough Allogeneic Cell Therapy Reversing Pancreatic Tumors in Preclinical Models
Lunai Bioworks Regains Nasdaq Compliance After Holding Annual Meeting
Reuters  ·  11-07
Lunai Bioworks Regains Nasdaq Compliance After Holding Annual Meeting
Lunai Bioworks Achieves Complete Regression of Pancreatic Tumors in Preclinical Models
Reuters  ·  11-05
Lunai Bioworks Achieves Complete Regression of Pancreatic Tumors in Preclinical Models
Lunai Bioworks Inc. held annual shareholder meeting
Reuters  ·  11-04
Lunai Bioworks Inc. held annual shareholder meeting
Lunai Bioworks Unveils AI Platform for Early Detection of Neurotoxic Compounds
Reuters  ·  10-30
Lunai Bioworks Unveils AI Platform for Early Detection of Neurotoxic Compounds
Lunai Bioworks Receives Nasdaq Notice for Market Value Noncompliance
Reuters  ·  10-30
Lunai Bioworks Receives Nasdaq Notice for Market Value Noncompliance
Lunai Bioworks Inc. Announces Landmark Study Identifying Prognostic Biomarkers in Duchenne Muscular Dystrophy
Reuters  ·  10-16
Lunai Bioworks Inc. Announces Landmark Study Identifying Prognostic Biomarkers in Duchenne Muscular Dystrophy
Lunai Bioworks Regains Nasdaq Compliance with Minimum Bid Price Requirement
Reuters  ·  10-16
Lunai Bioworks Regains Nasdaq Compliance with Minimum Bid Price Requirement
Lunai Bioworks Inc. Announces Date for Upcoming Annual Meeting of Stockholders
Reuters  ·  10-16
Lunai Bioworks Inc. Announces Date for Upcoming Annual Meeting of Stockholders
Lunai Bioworks Signs First Commercial Contract for AI-Based Early Alzheimer's Detection Program
Reuters  ·  10-06
Lunai Bioworks Signs First Commercial Contract for AI-Based Early Alzheimer's Detection Program
Lunai Bioworks Announces 10-for-1 Reverse Stock Split, Trades Under New Ticker "LNAI
Reuters  ·  09-30
Lunai Bioworks Announces 10-for-1 Reverse Stock Split, Trades Under New Ticker "LNAI

Introduction

Company Name.
Lunai Bioworks
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--